Dr. Homi Bhabha Balvaidnyanik Competition 2024-25 ( Standard IX )

The Rise of CAR T-Cell Therapy for Cancer Treatment

The Chimeric Antigen Receptor aka CAR T-cell itherapy marks a breakthrough in cancer care, introducing a novel strategy where traditional treatments have limitations. This technique involves engineering a patient's T-cells, a type of white blood cell integral to the immune system, to recognize and destroy cancer cells. Demonstrating significant efficacy in blood cancers. Ulke lymphoma and leukemia, researchers are now exploring its potential against solid tumors. Despite challenges such as cytokine release syndrome and neurotoxicity, ongoing advancements aim to enhance its safety and broaden its application. The strategy of combining CAR T-cells with vaccines to boost Immune responses is also being Investigated. Ploneering personalized medicine, CAR T-cell therapy is reshaping cancer treatment, heralding new possibilities in medical science.